John Michael Middlecott Banham - Director, Cyclacel Pharmaceuticals, Inc

As of June 29, 2020


What is John Michael Middlecott Banham's Net Worth?

The current estimated net worth of Cyclacel Pharmaceuticals, Inc's Director, John Michael Middlecott Banham, is estimated to be about $967.58K . John Michael Middlecott Banham owns about 36,847 units of Cyclacel Pharmaceuticals, Inc common stock. In the last 14 years at Cyclacel Pharmaceuticals, Inc, John Michael Middlecott Banham has sold an estimated value of $0 worth.

What is John Michael Middlecott Banham's Past Insider Trading?

John Michael Middlecott Banham's largest purchase order was 3,500 units , worth over $20.51K on September 8, 2006. In total, John Michael Middlecott Banham has made about 16 transactions over 14 years of their time at Cyclacel Pharmaceuticals, Inc. John Michael Middlecott Banham usually trades in May, with the busiest year in 2006.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is John Michael Middlecott Banham's' Mailing Address?

  • Mailing address is C/o Cyclacel Pharmaceuticals, Inc. 200 Connell Drive, Suite 1500 Berkeley Heights NJ 07922 NJ

What are Cyclacel Pharmaceuticals, Inc's Past Insider Trades?

Cyclacel Pharmaceuticals, Inc's most recent insider trade came on December 2, 2021 by Sam L Barker who sold 12 units worth $42.86 . In the last 15 years, insiders at Cyclacel Pharmaceuticals, Inc have sold an estimated value of $7.67M and bought an estimated value of $14.98M worth of shares. Insider trading is most common in May, with the busiest year in 2008. The most active traders at the company are Spiro Rombotis, President and CEO,  Morgan Stanley,  and David C. U'Prichard, Director .

Cyclacel Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1